Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan

  1. Mariko Harada Sassa
  2. Zhaoqing Lyu
  3. Tomoko Fujitani
  4. Kouji H. Harada
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Serological tests for SARS-CoV-2 coronavirus in pre-COVID-19 samples in Japan showed 1.5%–1.75% positives, and previous surveys might overestimate COVID-19 seroprevalence in several population of Japan. These false negatives could be excluded by combination of different diagnostics to 0.25%.

Related articles

Related articles are currently not available for this article.